Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia. (Q44498168)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 6 November 2013

Language	Label	Description	Also known as
English	Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.	scientific article published on 6 November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

based on heuristic

inferred from title

Annalisa Lonetti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

James A. McCubrey

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

João T. Barata

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Francesca Chiarini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Francesca Buontempo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

I L Antunes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

E Orsini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Ricci

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P L Tazzari

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P Pagliaro

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Melchionda

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

A Bertaina

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Locatelli

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

A M Martelli

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

6 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1196-1206

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

The role of HOX genes in normal hematopoiesis and acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

MicroRNAs in acute leukemia: from biological players to clinical contributors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Critical roles of the PI3K/Akt signaling pathway in T cell development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Targeting the phosphoinositide 3-kinase pathway in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Side population analysis using a violet-excited cell-permeable DNA binding dye.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

SP analysis may be used to identify cancer stem cell populations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Characterization of the mechanism of action of the pan class I PI3K inhibitor NVP-BKM120 across a broad range of concentrations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

The leukemic stem cell niche: current concepts and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Targeting nonclassical oncogenes for therapy in T-ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Proliferation of PTEN-deficient haematopoietic tumour cells is not affected by isoform-selective inhibition of p110 PI3-kinase and requires blockade of all class 1 PI3K activity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.369

21 January 2018

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24310736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24310736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24310736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24310736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24310736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2013.369

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310736%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44498168&oldid=2206690256"